Boc-D-His(Tos)-OH

Boc-D-His(Tos)-OH is a protected D-configuration histidine building block featuring a Boc-protected amino group and a tosyl (Tos) protected side-chain imidazole, providing strong control of chemoselectivity during peptide assembly. This derivative is commonly used in peptide chemistry where histidine side-chain reactivity must be masked to avoid side reactions, while the D-stereocenter supports stereochemically defined incorporation into peptides and peptidomimetics.

1. Stereodefined Peptide Synthesis

Boc-D-His(Tos)-OH is used as a histidine residue precursor for constructing peptides and peptide segments that require D-histidine incorporation. Researchers in custom peptide synthesis and peptide library development select this protected form to ensure the imidazole side chain remains controlled throughout coupling and deprotection cycles, improving reproducibility when assembling sequences that include neighboring reactive residues. The Boc protection pattern supports workflows where Boc-based strategies are employed for segment condensation and stepwise chain assembly, enabling reliable downstream handling of the peptide intermediate before final global deprotection and purification.

2. Histidine Side-Chain Protection Control

Boc-D-His(Tos)-OH supports workflows that demand robust side-chain masking of histidine to minimize undesired imidazole participation during peptide bond formation and intermediate processing. In practice, peptide chemists use the tosyl-protected imidazole to reduce competing side reactions that can occur when histidine is present in partially deprotected intermediates, particularly during iterative synthesis, fragment coupling, and purification steps. This makes the reagent valuable for preparing complex sequences where histidine must be introduced without compromising the integrity of other functional groups on the peptide scaffold.

3. Peptidomimetic and SAR Building Blocks

Boc-D-His(Tos)-OH is frequently incorporated into peptidomimetic development programs and structure-activity relationship (SAR) studies that rely on stereochemically defined amino acid substitutions. Medicinal chemistry groups and peptide-based lead optimization teams use D-histidine-containing constructs to probe sequence-dependent properties while maintaining synthetic control over the histidine side chain via the Tos protecting group. By providing a protected, residue-ready form, the reagent streamlines the preparation of analog panels where histidine position and stereochemistry are systematically varied, supporting efficient generation of peptide-like intermediates for subsequent biological and physicochemical characterization.

4. Pharmaceutical Intermediate Development

Boc-D-His(Tos)-OH is also used as a protected amino acid intermediate in the manufacture of advanced peptide intermediates destined for further chemical elaboration. Process development and specialty chemical manufacturing groups value the defined protection pattern because it helps maintain stability and reduces side reactions during intermediate isolation, conversion to activated forms, and controlled deprotection scheduling later in the synthesis of higher-complexity targets. This reagent is therefore relevant when D-histidine must be introduced early in a synthetic route while preserving functional group compatibility across multiple downstream transformations.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. Emu oil in combination with other active ingredients for treating skin imperfections

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling